SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Semler Scientific, Inc. (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025. Semler Scientific describes itself as a company that develops and markets technology products and services that assist its customers in evaluating and treating chronic diseases. For more information, submit a form, email attorney Aaron Dum ...

Group 1 - A class action lawsuit has been filed against Semler Scientific, Inc. for securities purchased between March 10, 2021, and April 15, 2025, inclusive [1] - Investors who purchased Semler Scientific securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - The lawsuit alleges that Semler Scientific made materially false and misleading statements and failed to disclose a material investigation by the U.S. Department of Justice regarding violations of the False Claims Act [5] Group 2 - The Rosen Law Firm, which is representing the investors, has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4] - Investors interested in joining the class action can do so by visiting the provided link or contacting the firm directly [3][6] - It is noted that no class has been certified yet, and investors are not represented by counsel unless they retain one [7]

NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who purchased or otherwise acquired Semler Scientific, Inc. (“Semler Scientific” or the “Company”) (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025, inclusive (the “Class Period”). The Complaint alleges that Defendants made false and/or misleadi ...

NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Semler Scientific, Inc. (“Semler Scientific” or “the Company”) (NASDAQ: SMLR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise ac ...

ATLANTA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Semler Scientific, Inc. (“Semler Scientific” or the “Company”) (NASDAQ: SMLR). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information, including allegations that:  (1) Semler Scientific did not disclose a material investigation by the United States Department of Justice (the "DOJ") into violations of the False Claims Act, ...

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Semler Scientific, Inc. securities between March 10, 2021, and April 15, 2025, due to alleged misleading statements and undisclosed investigations by the DOJ [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Semler Scientific failed to disclose a material investigation by the DOJ regarding violations of the False Claims Act, leading to materially false and misleading public statements [5]. - Investors who purchased Semler Scientific securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must file a motion with the court by October 28, 2025, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].

Core Viewpoint - A class action lawsuit has been filed against Semler Scientific, Inc. for failing to disclose an investigation by the U.S. Department of Justice regarding potential violations of the False Claims Act [1][2]. Allegations - The lawsuit alleges that Semler Scientific did not disclose a material investigation by the DOJ into possible violations of the False Claims Act during the class period from March 10, 2021, to April 15, 2025 [2]. - On February 28, 2025, Semler Scientific revealed it had received an initial civil investigative demand from the DOJ in July 2017, investigating whether the company violated the False Claims Act by marketing certain tests as reimbursable by Medicare [3]. - Following unsuccessful settlement discussions with the DOJ on February 11, 2025, the company faced a risk of a civil lawsuit, leading to a stock price drop of $4.03, or 9.38%, closing at $38.89 on March 3, 2025 [3]. Settlement and Financial Impact - On April 15, 2025, Semler Scientific reported to the SEC that it had reached a settlement agreement with the DOJ for $29.75 million, excluding attorney fees, but noted that further payments might be necessary and the risk of a DOJ lawsuit still exists [4]. - Following the settlement announcement, Semler Scientific's stock price fell by $3.40 per share, or 9.88%, closing at $31.00 on April 16, 2025 [4].

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 29, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Semler Scientific, Inc. ("Semler Scientific" or the "Company") (NASDAQ: SMLR) investors of a class action representing investors that bought securities between March 10, 2021 and April 15, 2025, inclusive (the "Class Period"). Semler Scientific investors have until October 28, 2025 to file a lead plaintiff motion. Investors are encouraged to co ...

Semler Scientific (SMLR 2.83%), the device maker best known for its QuantaFlo vascular testing system and recent pivot to bitcoin investing, reported earnings for the quarter on August 4, 2025. The headline result was a GAAP earnings per share (EPS) of $5.04, which soundly beat analyst expectations for a loss of $0.22 per share. However, this massive swing was primarily due to the value of the company's bitcoin holdings, which drove $83.8 million in unrealized gains. The core healthcare operations continued ...

Semler Scientific (SMLR) Q2 2025 Earnings Call August 04, 2025 04:30 PM ET Company ParticipantsJoe Burnett - Director of Bitcoin StrategyDouglas Murphy-Chutorian - CEO & Board MemberEric Semler - Executive ChairmanRenae Cormier - CFOJoe BurnettGood afternoon, and welcome to the Similar Scientific second quarter twenty twenty five financial results conference call. After today's prepared remarks, as time permits, management will take questions submitted prior to this call via email. Please note this event is ...